This inventor holds 1 USPTO granted patent. Top assignee: Jcr Pharmaceuticals Co., Ltd.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Tomoko Watanabe: Innovator in Metastasis Suppression
Introduction
Tomoko Watanabe is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of medical science, particularly in the development of metastasis suppressory agents. Her innovative work aims to improve treatment options for patients undergoing post-operative care.
Latest Patents
Watanabe holds a patent for her invention titled "Metastasis Suppressory Agents." This patent presents novel agents that feature a lowered degree of toxicity, comprising ursolic acid or its salt as an active ingredient. These agents can be administered to patients either orally or through injection, enabling effective post-operative ambulatory treatment.
Career Highlights
Watanabe is associated with JCR Pharmaceuticals Co., Ltd., where she continues to advance her research and development efforts. Her work has garnered attention for its potential to enhance patient outcomes in cancer treatment.
Collaborations
Throughout her career, Watanabe has collaborated with notable colleagues, including Hiromichi Ishikawa and Satoshi Nishimuro. These partnerships have contributed to the success of her innovative projects.
Conclusion
Tomoko Watanabe's contributions to the field of metastasis suppression highlight her dedication to improving patient care through innovative solutions. Her work exemplifies the impact of research and development in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile